{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T20:35:21Z","timestamp":1783629321153,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,22]],"date-time":"2011-10-22T00:00:00Z","timestamp":1319241600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s10147-011-0340-1","type":"journal-article","created":{"date-parts":[[2011,10,21]],"date-time":"2011-10-21T02:24:07Z","timestamp":1319163847000},"page":"46-53","source":"Crossref","is-referenced-by-count":32,"title":["Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images"],"prefix":"10.1007","volume":"18","author":[{"given":"Haruyuki","family":"Takaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Yamakado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiro","family":"Nakatsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Uraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Kashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,22]]},"reference":[{"key":"340_CR1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhep.2008.01.022","volume":"48","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Bruix J (2008) Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48:20\u201337","journal-title":"J Hepatol"},{"key":"340_CR2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00535-008-2263-9","volume":"44","author":"S Shiina","year":"2009","unstructured":"Shiina S (2009) Image-guided percutaneous ablation therapies for hepatocellular carcinoma. J Gastroenterol 44:122\u2013131","journal-title":"J Gastroenterol"},{"key":"340_CR3","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s00330-006-0461-5","volume":"17","author":"D Choi","year":"2007","unstructured":"Choi D, Lim HK, Rhim H et al (2007) Percutaneous radiofrequency ablation for early stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 17:684\u2013692","journal-title":"Eur Radiol"},{"key":"340_CR4","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/cncr.20892","volume":"103","author":"R Tateishi","year":"2005","unstructured":"Tateishi R, Shiina S, Teratani T et al (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103:1201\u20131209","journal-title":"Cancer"},{"key":"340_CR5","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1148\/radiol.2343040350","volume":"234","author":"R Lecioni","year":"2005","unstructured":"Lecioni R, Cioni D, Crocetti L et al (2005) Early stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961\u2013967","journal-title":"Radiology"},{"key":"340_CR6","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2214\/AJR.07.2970","volume":"190","author":"H Rhim","year":"2008","unstructured":"Rhim H, Lee MH, Kim YS et al (2008) Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas. AJR 190:1324\u20131330","journal-title":"AJR"},{"key":"340_CR7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jvir.2009.01.004","volume":"20","author":"BJ Park","year":"2009","unstructured":"Park BJ, Byun JH, Jin YH et al (2009) CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety. J Vasc Interv Radiol 20:490\u2013499","journal-title":"J Vasc Interv Radiol"},{"key":"340_CR8","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/01.RVI.0000132297.97113.C4","volume":"15","author":"T Shibata","year":"2004","unstructured":"Shibata T, Shibata T, Maetani Y et al (2004) Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome. J Vasc Interv Radiol 15:1323\u20131327","journal-title":"J Vasc Interv Radiol"},{"key":"340_CR9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.crad.2006.05.011","volume":"61","author":"S Gandhi","year":"2006","unstructured":"Gandhi S, Iannitti DA, Mayo-Smith WW et al (2006) Technical report: lipiodol-guided computed tomography for radiofrequency ablation of hepatocellular carcinoma. Clin Radiol 61:888\u2013891","journal-title":"Clin Radiol"},{"key":"340_CR10","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.3748\/wjg.v13.i32.4398","volume":"13","author":"K Kurokohchi","year":"2007","unstructured":"Kurokohchi K, Deguchi A, Masaki T et al (2007) Successful treatment of hypovascular advanced hepatocellular carcinoma with lipiodol-targeting intervention radiology. World J Gastroenterol 13:4398\u20134400","journal-title":"World J Gastroenterol"},{"key":"340_CR11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","volume":"35","author":"J Bruix","year":"2001","unstructured":"Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421\u2013430","journal-title":"J Hepatol"},{"key":"340_CR12","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1148\/radiol.2353042205","volume":"235","author":"SN Goldberg","year":"2005","unstructured":"Goldberg SN, Grassi CJ, Cardella JF et al (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235:728\u2013739","journal-title":"Radiology"},{"key":"340_CR13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.RVI.0000094584.83406.3e","volume":"14","author":"D Sacks","year":"2003","unstructured":"Sacks D, McClenny TE, Cardella JF et al (2003) Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14:199\u2013202","journal-title":"J Vasc Interv Radiol"},{"key":"340_CR14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2214\/ajr.183.3.1830583","volume":"183","author":"M Koda","year":"2004","unstructured":"Koda M, Ueki M, Maeda Y et al (2004) Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm. AJR 183:583\u2013588","journal-title":"AJR"},{"key":"340_CR15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2214\/AJR.07.2384","volume":"190","author":"H Rhim","year":"2008","unstructured":"Rhim H, Lim HK, Kim YS et al (2008) Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience. AJR 190:91\u201398","journal-title":"AJR"},{"key":"340_CR16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11604-009-0317-4","volume":"27","author":"N Miyamoto","year":"2009","unstructured":"Miyamoto N, Hiramatsu K, Tsuchiya K et al (2009) Sonazoid-enhanced sonography for guiding radiofrequency ablation for hepatocellular carcinoma: better tumor visualization by Kupffer-phase imaging and vascular-phase imaging after reinjection. Jpn J Radiol 27:185\u2013193","journal-title":"Jpn J Radiol"},{"key":"340_CR17","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jvir.2007.06.014","volume":"18","author":"J Kr\u00fccker","year":"2007","unstructured":"Kr\u00fccker J, Xu S, Glossop N et al (2007) Electromagnetic tracking for thermal ablation and biopsy guidance: clinical evaluation of spatial accuracy. J Vasc Interv Radiol 18:1141\u20131150","journal-title":"J Vasc Interv Radiol"},{"key":"340_CR18","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jvir.2007.04.022","volume":"18","author":"H Takaki","year":"2007","unstructured":"Takaki H, Yamakado K, Nakatsuka A et al (2007) Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5\u00a0cm or smaller: risk factors for local tumor progression. J Vasc Interv Radiol 18:856\u2013861","journal-title":"J Vasc Interv Radiol"},{"key":"340_CR19","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S1051-0443(07)61969-1","volume":"13","author":"K Yamakado","year":"2002","unstructured":"Yamakado K, Nakatsuka A, Ohmori S et al (2002) Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. J Vasc Interv Radiol 13:1225\u20131232","journal-title":"J Vasc Interv Radiol"},{"key":"340_CR20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/01.RVI.0000157780.44868.78","volume":"16","author":"K Sugimori","year":"2005","unstructured":"Sugimori K, Nozawa A, Morimoto M et al (2005) Extension of radiofrequency ablation of the liver by transcatheter arterial embolization with iodized oil and gelatin sponge: results in a pig model. J Vasc Interv Radiol 16:849\u2013856","journal-title":"J Vasc Interv Radiol"},{"key":"340_CR21","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.jvir.2009.09.003","volume":"20","author":"SG Kang","year":"2009","unstructured":"Kang SG, Yoon CJ, Jeong SH et al (2009) Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5\u00a0cm: a preliminary study. J Vasc Interv Radiol 20:1570\u20131577","journal-title":"J Vasc Interv Radiol"},{"key":"340_CR22","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1148\/radiol.2262012198","volume":"226","author":"T Livraghi","year":"2003","unstructured":"Livraghi T, Solbiati L, Meloni MF et al (2003) Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226:441\u2013451","journal-title":"Radiology"},{"key":"340_CR23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2214\/ajr.181.3.1810695","volume":"181","author":"T Ba\u00e8re de","year":"2003","unstructured":"de Ba\u00e8re T, Risse O, Kuoch V et al (2003) Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR 181:695\u2013700","journal-title":"AJR"},{"key":"340_CR24","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.3748\/wjg.15.2651","volume":"15","author":"WT Kong","year":"2009","unstructured":"Kong WT, Zang WW, Qiu YD et al (2009) Major complications after radiofrequency ablation for liver tumors: analysis of 255 patients. World J Gastroenterol 15:2651\u20132656","journal-title":"World J Gastroenterol"},{"key":"340_CR25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2214\/AJR.09.2917","volume":"194","author":"K Yamakado","year":"2010","unstructured":"Yamakado K, Nakatsuka A, Takaki H et al (2010) Subphrenic versus nonsubphrenic hepatocellular carcinoma: combined therapy with chemoembolization and radiofrequency ablation. AJR 194:530\u2013535","journal-title":"AJR"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-011-0340-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-011-0340-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-011-0340-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T10:37:25Z","timestamp":1559126245000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-011-0340-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,22]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["340"],"URL":"https:\/\/doi.org\/10.1007\/s10147-011-0340-1","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,22]]}}}